Casting a wider net: Immunosurveillance by nonclassical MHC molecules

PLoS Pathogens
M Patricia D'SouzaJonathan W Yewdell

Abstract

Most studies of T lymphocytes focus on recognition of classical major histocompatibility complex (MHC) class I or II molecules presenting oligopeptides, yet there are numerous variations and exceptions of biological significance based on recognition of a wide variety of nonclassical MHC molecules. These include αβ and γδ T cells that recognize different class Ib molecules (CD1, MR-1, HLA-E, G, F, et al.) that are nearly monomorphic within a given species. Collectively, these T cells can be considered "unconventional," in part because they recognize lipids, metabolites, and modified peptides. Unlike classical MHC-specific cells, unconventional T cells generally exhibit limited T-cell antigen receptor (TCR) repertoires and often produce innate immune cell-like rapid effector responses. Exploiting this system in new generation vaccines for human immunodeficiency virus (HIV), tuberculosis (TB), other infectious agents, and cancer was the focus of a recent workshop, "Immune Surveillance by Non-classical MHC Molecules: Improving Diversity for Antigens," sponsored by the National Institute of Allergy and Infectious Diseases. Here, we summarize salient points presented regarding the basic immunobiology of unconventional T cells, recent...Continue Reading

References

Mar 1, 1992·Human Immunology·D E GeraghtyJ A Hansen
Jan 1, 1997·Human Immunology·C Grimsley, C Ober
Mar 5, 1998·Nature·V M BraudA J McMichael
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·N LeeD E Geraghty
Feb 13, 2001·European Journal of Immunology·E J LepinC A O'Callaghan
Jan 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nel OttingRonald E Bontrop
Jul 12, 2005·Nature Immunology·Michael KochVincenzo Cerundolo
Sep 26, 2007·PLoS Pathogens·Deborah A LewinsohnDavid M Lewinsohn
Jun 19, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Matthias WölflPhilip D Greenberg
Apr 11, 2009·PLoS Pathogens·Jeff E GrotzkeDavid M Lewinsohn
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jodie P GoodridgeDaniel E Geraghty
Jul 9, 2010·PLoS Biology·Marielle C GoldDavid M Lewinsohn
Aug 31, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeff E GrotzkeDavid M Lewinsohn
May 9, 2012·Nature Medicine·Nathaniel LiddyBent K Jakobsen
Aug 18, 2012·Molecular Immunology·Margit H LampenThorbald van Hall
Oct 12, 2012·Nature·Lars Kjer-NielsenJames McCluskey
Dec 25, 2012·Cancer Immunology, Immunotherapy : CII·Emmet McCormackBent K Jakobsen
May 25, 2013·Science·Scott G HansenLouis J Picker
Jun 4, 2013·Nature Immunology·Ildiko Van RhijnD Branch Moody
Sep 11, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jodie P GoodridgeDaniel E Geraghty
Sep 13, 2013·Nature·Scott G HansenLouis J Picker
Dec 24, 2013·Nature Immunology·Annemieke de JongD Branch Moody
Jan 7, 2014·Annual Review of Immunology·Yueh-hsiu ChienMarc Bonneville
Feb 18, 2014·Cancer Immunology, Immunotherapy : CII·Giovanna BossiNamir J Hassan
Feb 18, 2014·Journal of Leukocyte Biology·Luis C Antón, Jonathan W Yewdell
May 27, 2014·Cell·Michael E BirnbaumK Christopher Garcia
Feb 24, 2015·Immunological Reviews·Ildiko Van Rhijn, D Branch Moody
May 8, 2015·Oncoimmunology·Marco LeporeGiulia Casorati
Jun 23, 2015·Frontiers in Immunology·Cláudia C Oliveira, Thorbald van Hall
Mar 8, 2016·Nature Methods·Michael J T StubbingtonSarah A Teichmann
Jul 13, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hongbing YangLucy Dorrell
Jul 23, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Dieter Kabelitz
Jul 28, 2016·Nature Immunology·Wilfredo F Garcia-BeltranMarcus Altfeld
Nov 4, 2016·Nature Communications·Stephanie GrasJamie Rossjohn

❮ Previous
Next ❯

Citations

Jan 15, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tereza AlmeidaAna Veríssimo
Nov 26, 2019·Current Protocols in Immunology·Michael N T SouterSidonia B G Eckle
Jul 18, 2020·Immunology and Cell Biology·Thomas S Watkins, John J Miles
Oct 6, 2020·F1000Research·Anita J ZaitouaMalini Raghavan
Nov 7, 2019·International Journal of Molecular Sciences·Leonid KanevskiyElena Kovalenko
Oct 14, 2020·Immunological Reviews·Daniela WeschHans-Heinrich Oberg
Mar 18, 2020·Allergy·Marcela de Lima MoreiraSidonia B G Eckle
Oct 7, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paula RuibalSimone A Joosten
Feb 12, 2020·Trends in Genetics : TIG·Jacek RadwanJamie Winternitz
Mar 7, 2021·International Journal of Molecular Sciences·Akhil ShuklaSubburaj Ilangumaran
May 16, 2021·Science Immunology·Bruce D Walker
Mar 1, 2020·Molecular Immunology·Emma J GrantStephanie Gras
Sep 2, 2021·Annual Review of Biomedical Data Science·Andrea CastroHannah Carter

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
enzyme-linked immunosorbent assay
peptide exchange

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.